Anthony R. Torres
Directeur/Membre du Conseil chez Convergent Bioscience Ltd.
Profil
Anthony R.
Torres is the founder of Great Basin Scientific, Inc. founded in 2003.
Currently, he is a Director at Convergent Bioscience Ltd.
and a Principal at Utah State University.
In the past, he worked as a Senior Scientist at HyClone Laboratories LLC, Utah State University, and Velico Medical, Inc. He also worked as a Professor at Yale University, a Researcher at the National Cancer Institute, and a Vice President-Research at Selective Cell Therapies.
Postes actifs de Anthony R. Torres
| Sociétés | Poste | Début |
|---|---|---|
| Utah State University | Corporate Officer/Principal | 17/09/2009 |
Convergent Bioscience Ltd.
 Convergent Bioscience Ltd. BiotechnologyHealth Technology Convergent Bioscience has become the Platinum Standard for characterizing proteins, peptides and other biologicals. It is the method of choice for charge based separations, due to its proprietary technology for whole column detection capillary isoelectric focusing (cIEF). The company's clients include emerging companies, as well as the largest pharmaceutical and biotechnology companies in the world, such as Abbott, Amgen, AstraZeneca, Biogen Idec, Bristol-Myers Squibb, Centocor, Eli Lilly, Genentech, Genzyme, GSK, Merck, Novartis, PDL, Pfizer, Sanofi Aventis, Serono and Wyeth. Its iCE280 is used from Formulation to lot release in QC. | Directeur/Membre du Conseil | 17/09/2009 |
Anciens postes connus de Anthony R. Torres
| Sociétés | Poste | Fin |
|---|---|---|
HyClone Laboratories LLC
 HyClone Laboratories LLC Containers/PackagingProcess Industries HyClone Laboratories, Inc. manufactures and markets cell culture products and bio-processing systems for life-science research and protein-based drug production. It provides serum-free and protein-free media, supplements, reagents, and process liquids; cell culture products; sera products, including fetal bovine serum, specialty FBS, bovine calf serum, and fetal bovine replacement; and disposable flexible containers/bags that are used for transporting, mixing, dispensing, and storing sterile liquids and powders during the manufacture of biotechnological drugs. The company was founded by Rex Spendlove and is headquartered in Logan, UT. | Directeur Technique/Scientifique/R&D | - |
| Selective Cell Therapies | Directeur Technique/Scientifique/R&D | - |
| Utah State University | Directeur Technique/Scientifique/R&D | - |
Velico Medical, Inc.
 Velico Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Velico Medical, Inc. operates as a pre-clinical medical technology company that develops and commercializes products for use in preparing and storing platelets and plasma, including a companion instrument and disposable product for spray drying plasma. Its products include FrontlineODP (on demand Plasma) and FrontlinePPS (Platelet Protection System). The company was founded by Robert W. Middleton and Cabot G. L. Henderson in 1991 and is headquartered in Beverly, MA. | Directeur Technique/Scientifique/R&D | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
HyClone Laboratories LLC
HyClone Laboratories LLC Containers/PackagingProcess Industries HyClone Laboratories, Inc. manufactures and markets cell culture products and bio-processing systems for life-science research and protein-based drug production. It provides serum-free and protein-free media, supplements, reagents, and process liquids; cell culture products; sera products, including fetal bovine serum, specialty FBS, bovine calf serum, and fetal bovine replacement; and disposable flexible containers/bags that are used for transporting, mixing, dispensing, and storing sterile liquids and powders during the manufacture of biotechnological drugs. The company was founded by Rex Spendlove and is headquartered in Logan, UT. | Process Industries |
Velico Medical, Inc.
Velico Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Velico Medical, Inc. operates as a pre-clinical medical technology company that develops and commercializes products for use in preparing and storing platelets and plasma, including a companion instrument and disposable product for spray drying plasma. Its products include FrontlineODP (on demand Plasma) and FrontlinePPS (Platelet Protection System). The company was founded by Robert W. Middleton and Cabot G. L. Henderson in 1991 and is headquartered in Beverly, MA. | Electronic Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Great Basin Scientific, Inc.
 Great Basin Scientific, Inc. Medical SpecialtiesHealth Technology Great Basin Scientific, Inc. is a molecular diagnostic testing company, which focuses on the development and commercialization of its patented, molecular diagnostic platform designed to test for infectious disease, especially hospital-acquired infections. The company was founded by David C. Ward, Anthony R. Torres and David Spafford on June 27, 2003 and is headquartered in Salt Lake City, UT. | Health Technology |
Convergent Bioscience Ltd.
Convergent Bioscience Ltd. BiotechnologyHealth Technology Convergent Bioscience has become the Platinum Standard for characterizing proteins, peptides and other biologicals. It is the method of choice for charge based separations, due to its proprietary technology for whole column detection capillary isoelectric focusing (cIEF). The company's clients include emerging companies, as well as the largest pharmaceutical and biotechnology companies in the world, such as Abbott, Amgen, AstraZeneca, Biogen Idec, Bristol-Myers Squibb, Centocor, Eli Lilly, Genentech, Genzyme, GSK, Merck, Novartis, PDL, Pfizer, Sanofi Aventis, Serono and Wyeth. Its iCE280 is used from Formulation to lot release in QC. | Health Technology |
| Selective Cell Therapies |